Jefferies Reaffirms Their Buy Rating on AstraZeneca (AZN)

Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of p17,500.00.

TipRanks Welcomes a New ETF – NYSE:RANK

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Leuchten is ranked #11349 out of 12331 analysts.

In addition to Jefferies, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued today. However, on the same day, HSBC downgraded AstraZeneca (LSE: AZN) to a Hold.

Jefferies analyst Michael Leuchten reaffirmed a Buy rating on AstraZeneca (AZN) with a price target of p17,500.00. While Berenberg Bank also issued a Buy rating, HSBC downgraded the stock to Hold. Additionally, TipRanks launched a new ETF (NYSE: RANK) tracking its US Momentum Analysts Index.

Jefferies analyst Michael Leuchten maintained a Buy rating on AstraZeneca today and set a price target of p17,500.00.

TipRanks Welcomes a New ETF – NYSE:RANK

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Leuchten is ranked #11349 out of 12331 analysts.

In addition to Jefferies, AstraZeneca also received a Buy from Berenberg Bank’s Luisa Hector in a report issued today. However, on the same day, HSBC downgraded AstraZeneca (LSE: AZN) to a Hold.